New FDA guidance meant to steer clinical trials of psychedelic compounds will play a major role in the eventual approval…
McAlinden Research PartnersJuly 12, 2023
Successful approval of Proposition 122 in Colorado made it the second state in the US to decriminalize hallucinogenic mushrooms like psilocybin. Clinics…
McAlinden Research PartnersNovember 17, 2022
Psychedelic medicine, focused on alternative mental health therapies that utilize drugs like LSD, MDMA and psilocybin, is becoming increasingly popular…
McAlinden Research PartnersJuly 18, 2022
Psychedelic drugs and therapies continue to show promise as a form of treatment for a wide variety of mental health disorders.…
McAlinden Research PartnersOctober 18, 2021
